top of page
  • Writer's picturePhoebe Fraser

Orbillion Bio secures funding and reaches cell-based beef production milestone

Californian B2B cell-based meat producer Orbillion Bio has secured funding to scale-up its cultivated meat production and develop its biotech platform.

The funding round was co-led by The Venture Collective and At One Ventures, with participation from Y Combinator, Metaplanet and other strategic investors, alongside university endowments. It brings Orbillion’s total capital raised to $15 million.

The start-up will use the money to scale its manufacturing, develop its technology and premium cell-based beef product – Wagyu beef – and to advance its regulatory path.

The announcement comes after the company’s successful 200-litre scale-up run of its cell-basewd meat in September last year, which it said was the largest production run undertaken by a pre-Series A company in the sector. This will enable the production of more than 4 million pounds of cultivated meat annually.

Orbillion said that the achievement will enable it to demonstrate its algorithm to transform 2D culture into 3D culture in record time and at low costs.

The company’s CEO and founder, Patricia Bubner, wrote on LinkedIn: “My team completed the largest-scale production run ever undertaken by a company at our stage already last year, in a powerful demonstration of both speed and cost-efficiency. Our technology first, capex second approach allows us to be fast and cost effective – asset-light in the truest sense of the word.”

She concluded: “With the fresh capital infusion from The Venture Collective, At One Ventures, Y Combinator and Metaplanet, we are now planning for the next step up in scale”.

Comments


bottom of page